Skip to main content

Table 6 Mean difference (95%CIs) of the BNP and CO

From: Comparative efficacy of eight oral Chinese patent medicines for dilated cardiomyopathy with heart failure: a Bayesian network meta-analysis

BNP (left lower part)

 

CO (right upper part)

  

TXL + CAM

 − 0.03 (− 0.73, 0.66)

 − 0.33 (− 1.58, 0.92)

 − 0.44 (− 1.56, 0.67)

 − 0.93 (− 1.46, − 0.40)

119.44 (− 115.88, 354.76)

QLQX + CAM

 − 0.30 (− 1.52, 0.92)

 − 0.41 (− 1.49, 0.67)

 − 0.90 (− 1.35, − 0.45)

175.85 (− 302.52, 654.21)

56.41 (− 387.74, 500.56)

SXBX + CAM

 − 0.11 (− 1.61, 1.39)

 − 0.60 (− 1.73, 0.53)

–

–

–

GTTL + CAM

 − 0.49 (− 1.47, 0.49)

 − 39.15 (− 247.65, 169.34)

 − 158.59 (− 267.70, − 49.49)

 − 215.00 (− 645.54, 215.54)

–

CAM

  1. The numbers in bold in the table indicate that there are statistically significant differences between this group and the CAM group
  2. BNP brain natriuretic peptide, CO cardiac output, QLQX Qili Qiangxin capsule, TXL Tongxinluo capsule, SXBX Shexiang Baoxin pill, GTTL Getong Tongluo capsule, CAM complementary and alternative medicine
Back to article page

Systematic Reviews

ISSN: 2046-4053